Search results for "MEDLINE"

showing 10 items of 2097 documents

2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid met…

2020

Lipid Metabolism Disorderbusiness.industrylcsh:RMEDLINElcsh:MedicineMedicineGeneral MedicineGuidelinesBioinformaticsbusinessArchives of Medical Science : AMS
researchProduct

An interview with Simonas Grybauskas

2018

LiteratureHistorybusiness.industryMEDLINEHistorical ArticleOrthodonticsBiography030206 dentistrylcsh:RK1-71503 medical and health sciences0302 clinical medicineOral history030220 oncology & carcinogenesislcsh:DentistryOral SurgerybusinessDental Press Journal of Orthodontics
researchProduct

Studies using the körperkoordinationstest für (ktk): A review

2014

Introduction When encouraging children to active lifestyle, a suitable test for the gross motor coordination, specifically mastering of fundamental motor skills, is of great use. To evaluate and choose a suitable test for different purposes it is important to know its usage in different settings. The Korperkoordinationstest fur Kinder (KTK) [1] is a test, which mainly focuses on gross motor coordination of both normal and impaired children. The KTK is quite simple and quick to administer, the same items cover all age groups (5–15 years). This study aims to introduce the KTK's usage on a basis of literature review. Specifically, the aim is to extract information on KTK's pros, cons and sugge…

Literaturebusiness.industryGross motor skillApplied psychologyMEDLINEPsycINFOlanguage.human_languageTest (assessment)GermanAge groupslanguageMedicineOrthopedics and Sports MedicinebusinessInclusion (education)Motor skillScience & Sports
researchProduct

Letter: effect of HCV eradication on cardiovascular disease-Authors' reply

2018

no abstract available

Liver CirrhosisHCV eradication cardiovascular diseasemedicine.medical_specialtyHepatologybusiness.industryGastroenterologyMEDLINEHepatitis CDiseaseHepatitis C Chronic030204 cardiovascular system & hematologymedicine.diseaseAntiviral Agents03 medical and health sciences0302 clinical medicineText miningCardiovascular DiseasesmedicineHumans030211 gastroenterology & hepatologyPharmacology (medical)Prospective StudiesbusinessIntensive care medicineProspective cohort study
researchProduct

Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study

2018

OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk factor for bleeding events. However, the relationship between platelet count and bleeding is still unclear. METHODS: We investigated the relationship between platelet count and major or clinical relevant nonmajor bleedings during a follow-up of ∼4 years. RESULTS: A total of 280 cirrhotic patients with different degrees of liver disease (67% males; age 64±37 years; 47% Child–Pugh B and C) were followed up for a median of 1,129 (interquartile range: 800–1,498) days yielding 953.12 patient-year of observation. The annual rate of any significant bleeding was 5.45%/year (3.57%/year and 1.8…

Liver CirrhosisMaleSettore MED/09 - Medicina Interna030204 cardiovascular system & hematologyGastroenterologySeverity of Illness IndexcjirrhosisACTIVATION0302 clinical medicineRisk FactorsMedicinePlateletProspective StudiesProspective cohort studyRISKAged 80 and overmedicine.diagnostic_testPRO-LIVERPlatelet cirrhosis gastrointestinal bleedingPlateletGastroenterologyASSOCIATIONMiddle AgedPrognosisItaly030211 gastroenterology & hepatologyFemaleGastrointestinal HemorrhageHumanAdultPlateletsmedicine.medical_specialtyPrognosiLiver CirrhosiMEDLINECOAGULATIONgastrointestinal bleedingSocio-culturaleHemorrhageHepatology; GastroenterologyFollow-Up Studie03 medical and health sciencesText miningInternal medicineSeverity of illnessENDOTOXEMIAPro-Liver StudyHumansHEMOSTASISInternational Normalized RatioAgedProportional Hazards ModelsProthrombin timeCirrhosiHepatologyPlatelet Count Bleeding Liver Cirrhosisbusiness.industryProportional hazards modelPlatelet CountRisk FactorcirrhosisHepatologybleedingThrombocytopeniaProspective StudieTHROMBOSISPlatelets cjirrhosis bleeding PRO-LIVERProportional Hazards ModelProthrombin TimebusinessDECOMPENSATED CIRRHOSISFollow-Up Studies
researchProduct

Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice.

2020

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) prevalence has increased in the past two decades, resulting in a significant but under-recognised public health burden. This impacts the prevalence of advanced fibrosis, end-stage liver disease and associated extrahepatic manifestations. To understand the challenges in recognising patients with advanced fibrosis due to NASH and develop a standardised approach to screen these patients, the authors of this document provided their opinions and expertise from practice and published evidence to identify key challenges and current approaches for diagnosing NASH. The severity of liver fibrosis due to NASH is the main …

Liver Cirrhosismedicine.medical_specialtyBest practicePsychological interventionMEDLINEDiseasedigestive systemRisk Assessment03 medical and health sciencesLiver disease0302 clinical medicineNon-alcoholic Fatty Liver DiseaseNonalcoholic fatty liver diseasemedicineHumansMass ScreeningIntensive care medicinebusiness.industryPublic healthGastroenterologymedicine.diseaseAdvanced fibrosis Best practice Identification NAFLD NASHdigestive system diseasesEarly Diagnosis030220 oncology & carcinogenesisPractice Guidelines as TopicDisease Progression030211 gastroenterology & hepatologyIdentification (biology)businessAlgorithmsJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.

2021

Liver Cirrhosismedicine.medical_specialtyCirrhosisHepatologybusiness.industryGastroenterologyMEDLINEProton Pump Inhibitorsmedicine.diseaseGastroenterologyRisk FactorsInternal medicinemedicineHumansIn patientbusinessThe American journal of gastroenterology
researchProduct

Traditional Chinese Medicine (TCM) for fibrotic liver disease: Hope and hype

2014

Liver Cirrhosismedicine.medical_specialtyCirrhosisMEDLINEHolistic HealthTraditional Chinese medicineHolistic healthGastroenterologyHepatitisLiver diseaseFibrosisInternal medicineChinese traditionalHBVmedicineHumansMedicine Chinese TraditionalIntensive care medicineInflammationHepatitisClinical Trials as TopicHerbHepatologybusiness.industryNASHmedicine.diseaseFibrosisTCMCirrhosisLiverHCVCollagenAntifibroticbusinessDrugs Chinese HerbalJournal of Hepatology
researchProduct

Management of hepatic encephalopathy in Germany: a survey among physicians

2020

 Hepatic encephalopathy (HE) is a severe complication of liver cirrhosis with impairment of quality of life and prognosis. Management patterns among physicians have not been investigated yet. A questionnaire containing 17 questions was sent out to 1468 gastroenterologists and 120 general practitioners (GPs). It included questions regarding diagnostic, therapeutic, and management strategies used in patients with overt HE (OHE) and covert HE (CHE). The response rate was 12 % (n = 172) for gastroenterologists and 45 % (n = 54) for GPs. Of gastroenterologists, 26.7 % examine patients with an initial diagnosis of liver cirrhosis regarding HE. Gastroenterologists favored a combination of differen…

Liver Cirrhosismedicine.medical_specialtyCirrhosisMEDLINEPhysical examinationRifaximin03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGastrointestinal AgentsQuality of lifeGeneral PractitionersGermanySurveys and QuestionnairesSecondary PreventionmedicineHumans030212 general & internal medicinePractice Patterns Physicians'Disease management (health)Hepatic encephalopathyResponse rate (survey)medicine.diagnostic_testbusiness.industryGastroenterologistsGastroenterologyDisease Managementmedicine.diseaseLactuloseRifaximinchemistryHepatic EncephalopathyEmergency medicineQuality of Life030211 gastroenterology & hepatologybusinessZeitschrift für Gastroenterologie
researchProduct

Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis?

2019

not available

Liver Cirrhosismedicine.medical_specialtyCirrhosisbusiness.industryMEDLINEPeritonitisHepatitis CPeritonitismedicine.diseaseChronic liver diseaseVitamin D DeficiencyGastroenterologyHepatitis Cvitamin D deficiencyVitamin D chronic liver disease deficiency hepatic encephalopathyRisk FactorsInternal medicineHepatic EncephalopathyEmergency MedicineInternal MedicineVitamin D and neurologyMedicineHumansbusinessHepatic encephalopathy
researchProduct